Nucleic acids are one of several macromolecules found in the body in
addition to fats, proteins, and carbohydrates. A nucleic acid is a
polymer composed of four nucleotides linked together in a long chain
known as polynucleotide. A nucleic acid consists of DNA, RNA, and
protein. Nucleic acid extraction and purification is widely used in
next generation sequencing, nucleic acid library preparation, gene
therapy research and various other areas such as plant and animal
tissue culture. Genome analysis in cloning, drug discovery, disease
diagnosis, and stem cell research has increased considerably in the
recent past. Increased research and developmental activities
undertaken by pharmaceutical companies have resulted in the launch of
better biological drugs.
The rising demand for pure nucleic acids in pharmaceutical and
biotechnological industries and growing use of nucleic acid-based
tests in diagnosis have propelled the growth of this market across
the globe. Increasing applications of these techniques in various
fields such as genetic engineering, life science research, forensics
and molecular diagnostics, and government funding in R&D, and
recent technological innovations are expected to fuel the growth of
this market. Oncology, neurological diseases, and autoimmune diseases
have been key focus areas in personalized medicine. According to
Cancer Research U.K., over 14 million adults were diagnosed with some
type of cancer in 2012 globally. The data further states that more
than 8 million mortalities were recorded in 2012 due to cancer. Such
high prevalence of cancer has demanded better therapeutic
alternatives with fewer side effects. Autoimmune diseases are another
major concern, as scientists have been unsuccessful in finding cure
for these diseases. According to American Autoimmune Related Diseases
Association, Inc., in the U.S., over 23 million individuals suffer
from autoimmune disease.
The nucleic acid extractors market is segmented by product type,
application, end user, and geography. Based on product, the market is
segmented into semi-automatic nucleic acid extractors and
fully-automatic nucleic acid extractors. Based on application, the
market is segmented into genomic DNA extraction, blood DNA
extraction, RNA extraction, and plasmid DNA extraction. Based on end
user, the segmentation includes academic research, hospitals and
diagnostic centers, pharmaceutical and biotechnology companies,
contract research organizations, and other.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35726
Based on geography, the global nucleic acid extractors market is
segmented into five regions, North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America dominated
the global market in 2016, owing to the large academic and
pharmaceutical customer base. Various pharmaceutical giants have
their research facilities in the U.S. Some of these include Novartis,
GSK, Pfizer, Bristol-Myers Squibb, and Ionis Pharmaceuticals. Europe
is expected to be the second largest market in terms of revenue and
the market is expected to grow during the forecast period due to
rapid economic development and increase in health care expenditure in
this region. Asia Pacific is expected to register high growth during
2017-2025, due to factors such as increasing R&D expenditure and
technological advancements in countries in the region. In Middle East
& Africa, and Latin America, healthcare projects and growing
economies drives the market of nucleic acid extractors.
Some of the key players operating in the global nucleic acid
extractors market include ELITechGroup, Analytik Jena AG, AUTOGEN
Inc., Bio-Rad Laboratories, Inc., Hamilton Company, Promega
Corporation, and TBG Diagnostics Limited.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=35726<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment